Ray Hill

Ray Hill

Director/Board Member bei ADDEX THERAPEUTICS LTD

Vermögen: 84 653 $ am 31.03.2024

79 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Raymond G.
Hill is a Chairman at Avilex Pharma ApS, an Independent Director at Asceneuron SA, a Member at Royal Pharmaceutical Society and a Member at The Research Board, Inc. He is on the Board of Directors at Addex Therapeutics Ltd.
and Asceneuron SA. Dr. Hill was previously employed as an Independent Director by Karolinska Development AB, an Independent Director by Orexo AB, an Executive Director-Licensing & External Research by Merck Sharp & Dohme Research Laboratories, a Chairman by Merck & Co., Inc., an Executive Director by Merck Sharp & Dohme Corp., an Executive Director-Pharmacology by Neuroscience Research Centre, a Group Director-Pharmacology by SKF (U.K.) Ltd., a Member-Park Davis Research Unit by University of Cambridge, a Trustee by Academy of Medical Sciences, a President & Trustee by British Pharmacological Society, a Non-Executive Director by Covagen AG, and a Non-Executive Director by Lectus Therapeutics Ltd.
He received his undergraduate degree from the University of London and a doctorate degree from the University of London.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.12.2022 797 563 ( 0,43% ) 84 653 $ 31.03.2024

Aktive Positionen von Ray Hill

UnternehmenPositionBeginn
ADDEX THERAPEUTICS LTD Director/Board Member 11.06.2015
Corporate Officer/Principal -
Director/Board Member -
Chairman -
Corporate Officer/Principal -
Alle aktiven Positionen von Ray Hill

Ehemalige bekannte Positionen von Ray Hill

UnternehmenPositionEnde
OREXO AB Director/Board Member 01.01.2019
ADDEX THERAPEUTICS LTD Director/Board Member 20.03.2013
Merck Sharp & Dohme Research Laboratories Corporate Officer/Principal 30.04.2008
Director/Board Member 01.01.2008
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Ray Hill im Detail an

Ausbildung von Ray Hill

University of London Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ray Hill im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

18

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
MERCK & CO., INC.

Health Technology

OREXO AB

Health Technology

ADDEX THERAPEUTICS LTD

Health Technology

KAROLINSKA DEVELOPMENT AB

Finance

Private Unternehmen12

Health Technology

Commercial Services

Commercial Services

Merck Sharp & Dohme Research Laboratories

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Producer Manufacturing

Commercial Services

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an